R. C. Chaves

Involvement of monoaminergic targets in the antidepressant- and anxiolytic-like effects of the synthetic alkamide riparin IV: Elucidation of further mechanisms through pharmacological, neurochemistry and computational approaches

C. Andrade, D. Macêdo, J. Barbosa-Filho, 2020, Behavioural Brain Research.

The neuroprotective effect of Riparin IV on oxidative stress and neuroinflammation related to chronic stress-induced cognitive impairment

M. Fonteles, F. Sousa, A. Carvalho, 2020, Hormones and Behavior.

Thymol reverses depression‐like behaviour and upregulates hippocampal BDNF levels in chronic corticosterone‐induced depression model in female mice

D. Macêdo, José Tiago Valentim, I. Oliveira, 2019, The Journal of pharmacy and pharmacology.

Behavioral alterations and pro-oxidant effect of a single ketamine administration to mice

D. Macêdo, S. Vasconcelos, M. Fonteles, 2010, Brain Research Bulletin.

Riparin II ameliorates corticosterone-induced depressive-like behavior in mice: Role of antioxidant and neurotrophic mechanisms

D. Macêdo, J. Barbosa Filho, José Tiago Valentim, 2018, Neurochemistry International.

Reversal effect of Riparin IV in depression and anxiety caused by corticosterone chronic administration in mice

D. Macêdo, S. Vasconcelos, F. Sousa, 2019, Pharmacology Biochemistry and Behavior.

Is Riparin III a promising drug in the treatment for depression?

D. Macêdo, S. Vasconcelos, M. Fonteles, 2021, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.